Response to Comments: MolDX: Pigmented Lesion Assay

This document is a response-to-comments notice regarding the MolDX: Pigmented Lesion Assay and does not contain clinical coverage criteria. It directs readers to the Local Coverage Determination MolDX: Pigmented Lesion Assay (L38178), whose notice period began 2020-02-27 and which becomes effective 2020-04-12; the LCD's comment period ran from 2019-04-25 to 2019-06-09.

"This document is a Response to Comments about the MolDX: Pigmented Lesion Assay and does not itself define clinical coverage criteria; refer to LCD MolDX: Pigmented Lesion Assay (L38178) for covera..."

Sign up to see full coverage criteria, indications, and limitations.